Earlier this year the Pennsylvania Senate passed the Medical Cannabis Act. Today, that legislation remains in the House of Representatives where the specifics continue to be debated and negotiated. With a final vote on the Bill possible in the coming months, now is the time to look closely at the language being considered and learn precisely how impactful the medical cannabis industry will be on your legal practice.
Prepare to advise your clients about the proposed regulations
Our distinguished faculty will provide an in-depth analysis of the possible regulatory system surrounding the growing, processing and distributing of medical cannabis in Pennsylvania. They will also examine the ethical implications of representing a client in the cannabis industry.
Attend to have your questions such as these answered
- What will be included in the permitting application process for growers, processors and distributors?
- What are the zoning, municipal and land use implications triggered by the passage of this law?
- What medical conditions will qualify a patient for medical cannabis and will the list of conditions expand?
- What ethical issues can a lawyer expect to face in this industry?
- And more!
Our impressive faculty
Course planner
William G. Roark, Esq.
Hamburg, Rubin, Mullin, Maxwell & Lupin, P.C., Lansdale
Faculty
Representative Kerry Benninghoff
Pennsylvania House of Representatives, Harrisburg
Hilary Bricken, Esq.
Harris Moure, PLLC, Seattle, WA
Representative Timothy P. Briggs
Pennsylvania House of Representatives, Harrisburg
Michael Bronstein
Bronstein & Weaver, Inc., Bryn Mawr
Christen G. Pionzio, Esq.
Hamburg, Rubin, Mullin, Maxwell & Lupin, P.C., Lansdale
Andrew B. Sacks, Esq.
Sacks Weston LLC, Philadelphia
